Collagen remains the most commercially significant protein in anti-aging skincare — but the science around it has evolved considerably. Formulators who once relied on single-mechanism actives are increasingly seeking ingredients that address collagen biology at multiple points simultaneously. Collagen degradation is not a single event. It unfolds across activation, maturation, matrix assembly, ECM repair, and oxidative protection — and a credible formulation strategy has to engage all of them.
Natori Collacell VX is built around exactly this logic. It is a lipid-phase active complex engineered to support collagen across its full biological lifecycle, addressing five distinct pathways within a single ingredient.
A Five-Pathway System
The approach behind Collacell VX is architectural rather than additive. Each component targets a specific and distinct mechanism within the collagen lifecycle — from gene expression through to structural protection. The result is a complex that works across all five collagen pathways simultaneously.
Collagen Gene Activation and Synthesis
VC-IP (Ascorbyl Tetraisopalmitate) upregulates COL-I expression via TGF-β and promotes COL-IV synthesis. Bakuchiol stimulates COL-I, COL-III, and COL-IV gene expression, with clinical data demonstrating superior collagen stimulation versus retinol at equivalent concentrations — without the irritation profile that limits retinol’s application in sensitive-skin formulations.
Together, these two actives address collagen at the gene level, triggering upstream synthesis that no single-ingredient approach can match.
Collagen Maturation and Triple-Helix Stabilisation
VC-IP acts as an essential cofactor for prolyl and lysyl hydroxylase — the enzymes responsible for hydroxylating proline and lysine residues during post-translational collagen processing. Hydroxyproline and hydroxylysine are structurally critical: they stabilise the collagen triple helix and enable proper cross-linking in the extracellular matrix.
Without adequate hydroxylation, collagen cannot form the stable, organised fibrils that provide dermal density and structural integrity. Collacell VX addresses this step directly, supporting not just synthesis but proper collagen architecture.
Matrix Assembly and ECM Signalling
Dipalmitoyl Hydroxyproline mimics collagen fragments to enhance fibroblast-ECM communication. It increases Type I collagen organisation by approximately 50% and supports dermal density and structural reinforcement by improving the signalling environment in which fibroblasts operate.
This pathway is distinct from synthesis stimulation — it ensures that the collagen being produced is deposited and organised effectively within the dermal matrix.
Collagen Protection — Broad-Spectrum MMP Inhibition
Matrix metalloproteinases (MMPs) are the primary enzymes responsible for collagen degradation. Collacell VX delivers multi-target MMP inhibition through three separate actives:
Tocotrienol downregulates MMP-1, MMP-2, MMP-3, and MMP-9 gene expression. Bakuchiol inhibits MMP-1 activity at 50% and MMP-12 at 70%. Rhodotorula Oil further downregulates MMP-1 and MMP-3. The combined inhibition profile is significantly broader than what any single inhibitor provides, protecting newly synthesised collagen from enzymatic breakdown across multiple MMP subtypes.
Bioavailability Enhancement
An active complex can only deliver results if it reaches the target tissue. Caprylic/Capric Triglyceride (MCT) and Glycolipids enhance the penetration of the lipophilic actives in Collacell VX, ensuring the complex reaches the dermal layer where collagen synthesis and matrix organisation occur.
Natori Collacell VX is an oil-soluble, lipid-phase active with a recommended dosage of 1.0–5.0%. Its INCI: Ascorbyl Tetraisopalmitate, Bakuchiol, Dipalmitoyl Hydroxyproline, d-α-Tocopheryl Acetate, Tocotrienol, Rhodotorula Oil, Glycolipids, Caprylic/Capric Triglyceride.
It integrates cleanly into serums, facial oils, emulsions, and bi-phase products targeting mature skin, collagen loss, skin firmness, and brightening.
Source Natori Collacell VX from Ecoori
Ecoori supplies Natori Collacell VX with full technical documentation, formulation guidance, and regulatory support across Southeast Asia and South Korea. Samples are available for qualified formulators and product development teams.
Contact us to discuss application fit, dosage recommendations, and compatibility with your current formulation platform.
English